Local Tumor Behavior Associated With Survival Among Patients With Paraganglioma of the Head and Neck.
Harley RJ, Lee JH, Ostrander BT, Finegersh A, Pham TB, Tawfik KO, Ren Y, Faraji F, Friedman RA.
OTO Open. 2022 Mar 31;6(1):2473974X221086872. doi: 10.1177/2473974X221086872. eCollection 2022 Jan-Mar.
PMID:35571573
The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma.
Samsudin I, Page MM, Hoad K, Chubb P, Gillett M, Glendenning P, Vasikaran S.
Ann Clin Biochem. 2018 Nov;55(6):679-684. doi: 10.1177/0004563218774590. Epub 2018 May 2.
PMID:29660998
[Diagnosis of pheochromocytoma and paraganglioma: the clonidine suppression test in patients with borderline elevations of plasma free normetanephrine].
Därr R, Lenders JW, Stange K, Kindel B, Hofbauer LC, Bornstein SR, Eisenhofer G.
Dtsch Med Wochenschr. 2013 Jan;138(3):76-81. doi: 10.1055/s-0032-1327395. Epub 2013 Jan 8.
PMID:23299341
A case of a borderline adrenal oncocytoma in a 62-year old female.
Behaeghe O, Geurde B, Jourdan JL, Bodson C, Seydel B, Lacremans D.
Quantitative analysis of (68)Ga-DOTA(0)-Tyr(3)-octreotate positron emission tomography/computed tomography imaging for the differential diagnosis of primary pheochromocytoma and paraganglioma.
Ma G, Du J, Zhang X, Liu J, Xu X, Xu B, Guan Z.
Quant Imaging Med Surg. 2022 Apr;12(4):2427-2440. doi: 10.21037/qims-21-652.
PMID:35371938
A review of the management of positive biochemical screening for phaeochromocytoma and paraganglioma: a salutary tale.
Garrahy A, Casey R, Wall D, Bell M, O'Shea PM.
Int J Clin Pract. 2015 Jul;69(7):802-9. doi: 10.1111/ijcp.12612. Epub 2015 Feb 4.